Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society

Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society

Bibliographic Details
Main Authors:	Bu Kyung Kim, Chong Hwa Kim, Yong-Ki Min
Format:	Article
Language:	English
Published:	Academya Publishing Co. 2021-08-01
Series:	Endocrinology and Metabolism
Online Access:	http://www.e-enm.org/upload/pdf/enm-2021-1193.pdf

Similar Items

Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
by: Athanasios D. Anastasilakis, et al.
Published: (2021-01-01)

COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
by: Cheol Ryong Ku, et al.
Published: (2021-08-01)

Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology
by: Jung Hee Kim, et al.
Published: (2020-06-01)

Severe rebound effect and multiple fractures after denosumab discontinuation in patient with chronic kidney disease stage 5
by: Sergei Mazurenko, et al.
Published: (2020-10-01)

Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale
by: Alexander Tyan, MD, et al.
Published: (2019-06-01)

Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation
by: Athanasios D. Anastasilakis, et al.
Published: (2020-06-01)

Obesity and Hyperglycemia in Korean Men with Klinefelter Syndrome: The Korean Endocrine Society Registry
by: Seung Jin Han, et al.
Published: (2016-12-01)

Effect of risedronate on bone loss at discontinuation of denosumab
by: Michel Laroche, et al.
Published: (2020-12-01)

Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018
by: Eun Hwa Choi, et al.
Published: (2019-07-01)

The Efficacy of Denosumab in the Management of a Tibial Paediatric Aneurysmal Bone Cyst Compromised by Rebound Hypercalcaemia
by: Matthew Harcus, et al.
Published: (2020-01-01)

Joint Statement of the Ad-hoc Committee of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on Tobacco Lawsuits on the Causal Link Between Tobacco Smoking and Lung Cancer
Published: (2015-05-01)

Joint Statement of the Ad-hoc Committee of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on Tobacco Lawsuits on the Causal Link Between Tobacco Smoking and Lung Cancer
Published: (2015-06-01)

Investigating Denosumab discontinuation in the TgRANKL osteoporotic mouse model
by: Vagelis Rinotas, et al.
Published: (2021-04-01)

Importance of a Diversity Committee in Advancing the Korean Society of Gastroenterology: A Survey Analysis
by: Sung Eun Kim, et al.
Published: (2019-09-01)

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
by: Jonathan D. Adachi, et al.
Published: (2017-04-01)

Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak
Published: (2020-04-01)

Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak
Published: (2020-04-01)

Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
by: Pathan F, et al.
Published: (2021-05-01)

Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report
by: Masafumi Kashii, et al.
Published: (2020-12-01)

Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation
by: Elena Gonzalez-Rodriguez, et al.
Published: (2018-01-01)

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
by: Tae-Wook Kong, et al.
Published: (2020-03-01)

To rebound or not to rebound
by: Bethany A Stahl, et al.
Published: (2017-10-01)

Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation
by: D. Barouch, et al.
Published: (2019-12-01)

Statement to Boston School Committee.
Published: ()

Endocrine Society of India management guidelines for patients with thyroid nodules: A position statement
by: A G Unnikrishnan, et al.
Published: (2011-01-01)

Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation
by: Katharina Jähn-Rickert, et al.
Published: (2020-05-01)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
by: Takako Suzuki, et al.
Published: (2017-06-01)

Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
by: Po-Ting Liu, et al.
Published: (2020-10-01)

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists
by: Mimi Kim, et al.
Published: (2017-07-01)

Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
by: Kyu Yeon Hur, et al.
Published: (2020-02-01)

Consensus statement on coronary intervention during the coronavirus disease 19 pandemic: from the Korean Society of Interventional Cardiology
by: Kwan Yong Lee, et al.
Published: (2020-07-01)

Consensus Statement by the Expert Advisory Committee
by: article Editorial
Published: (2012-02-01)

Statement at UNHCR’s 2003 Executive Committee
by: Omar Ramadhan Mapuri
Published: (2004-05-01)

A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial
by: Chia-Che Lee, et al.
Published: (2021-09-01)

Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013
by: Dae Sun Jo, et al.
Published: (2013-06-01)

Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
by: Kyu Yeon Hur, et al.
Published: (2020-03-01)

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01)

Clinical applications of Doppler ultrasonography for thyroid disease: consensus statement by the Korean Society of Thyroid Radiology
by: Jin Chung, et al.
Published: (2020-10-01)

Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report
by: Yves Maugars, et al.
Published: (2020-08-01)

The Role Of Denosumab
by: Raditya Pria Utama, et al.
Published: (2019-07-01)